O'Neill Gilmore Neil
Editas Medicine Inc · CEO
O'Neill Gilmore Neil is listed in filings as CEO at Editas Medicine Inc. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Editas Medicine Inc (EDIT). The current snapshot covers public activity from Sep 6, 2024 to Jun 5, 2026. Reported amounts are shown as $41.5K to $10.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $11k5.4k shares | SellMar 3, 2026 | $2.02 | $2.96 | |
| $12k5.6k shares | SellDec 3, 2025 | $2.15 | $2.96 | |
| $15k5.6k shares | SellSep 3, 2025 | $2.60 | $2.96 | |
| $26k15.2k shares | SellJun 3, 2025 | $1.72 | $2.96 | |
| $28k16.6k shares | SellMar 4, 2025 | $1.71 | $2.96 | |
| $3.4k1.6k shares | SellDec 3, 2024 | $2.08 | $2.96 | |
| $5.3k1.6k shares | SellSep 4, 2024 | $3.42 | $2.96 |